PAM
PMVP icon

Panagora Asset Management’s PMV Pharmaceuticals PMVP Stock Holding History

Panagora Asset Management’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-72,089
Closed -$101K – 1246
2025
Q3 		$101K Sell
72,089
-14,831
-17% -$20.5K ﹤0.01% 1128
2025
Q2 		$92.1K Sell
86,920
-2,711
-3% -$2.66K ﹤0.01% 1093
2025
Q1 		$97.7K Hold
89,631
– – ﹤0.01% 1077
2024
Q4 		$135K Hold
89,631
– – ﹤0.01% 1100
2024
Q3 		$134K Buy
+89,631
New +$138K ﹤0.01% 1170
2024
Q2 		– Sell
-18,705
Closed -$31.8K – 1267
2024
Q1 		$31.8K Buy
+18,705
New +$34.9K ﹤0.01% 1201

Other funds holding PMVP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Panagora Asset Management's PMVP Position: Q4 2025 in Review

Panagora Asset Management sold out of PMV Pharmaceuticals (PMVP) in Q4 2025, closing a stake of 72,089 shares — an estimated $101K sold.

Panagora Asset Management first reported a position in PMVP in Q1 2024 and held it in 6 quarters. The position peaked at $135K in Q4 2024. 63 funds tracked by Wall St. Rank hold PMVP as of Q4 2025.

  • Panagora Asset Management reported no remaining PMV Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Panagora Asset Management sold 72,089 PMV Pharmaceuticals shares in Q4 2025, an estimated $101K.
  • Panagora Asset Management first reported a position in PMV Pharmaceuticals in Q1 2024 and held it in 6 quarters.
  • Panagora Asset Management's PMV Pharmaceuticals position peaked at $135K in Q4 2024.
  • 63 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q4 2025.

Based on Panagora Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.